Y. She and Z. Liu, “Effect of Peptide Drug Liraglutide Nano-Formulation Combined with Sodium-Glucose Cotransporter-2 Inhibitor on Blood Lipids in Patients with Type 2 Diabetes: Peptide Drug Liraglutide Nano-Formulation and Type 2 Diabetes”, Cell Mol Biol (Noisy-le-grand), vol. 68, no. 3, pp. 221–228, Mar. 2022.